Sleep Apnea Device Marker Inspire's Stock Rises on Improved Outlook

Core Insights - Inspire Medical Systems reported preliminary results indicating second-quarter and full-year revenue exceeding analysts' estimates [2] - The company expects second-quarter sales to be 30% higher compared to the same period last year [2] - Inspire anticipates full-year revenue growth of 26% to 28% for 2024, with projected revenue between $788 million and $798 million [2] Financial Performance - The expected second-quarter revenue is $195.9 million, reflecting a 30% increase year-over-year [2] - The previous revenue outlook for the full year was $775 million to $785 million, which has been revised upward [2] - Inspire's shares rose approximately 4% following the announcement, although they remain down about 35% year-to-date [2] Management Commentary - CEO Tim Herbert expressed increased confidence in strong continued revenue growth for the second half of the year [2]